Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.06 USD | +1.98% | +10.75% | +14.44% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 7.521 | 233.5 | 63.09 | 31.37 | 43.56 | 51.12 | - | - |
Enterprise Value (EV) 1 | 7.521 | 233.5 | 63.09 | 31.37 | 43.56 | 51.12 | 51.12 | 51.12 |
P/E ratio | -0.43 x | -0.98 x | -1.89 x | -0.37 x | -1.1 x | -1.42 x | -2.29 x | -2.22 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - | - | - |
EV / EBITDA | -584,522 x | - | - | - | - | - | - | - |
EV / FCF | -0.54 x | -15.3 x | - | - | - | -1.06 x | -0.76 x | -0.57 x |
FCF Yield | -184% | -6.52% | - | - | - | -93.9% | -131% | -174% |
Price to Book | 0.79 x | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 720 | 15,160 | 14,307 | 13,757 | 24,198 | 24,813 | - | - |
Reference price 2 | 10.44 | 15.40 | 4.410 | 2.280 | 1.800 | 2.060 | 2.060 | 2.060 |
Announcement Date | 3/17/20 | 3/30/21 | 3/24/22 | 3/30/23 | 3/28/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - |
EBITDA | -12.87 | - | - | - | - | - | - | - |
EBIT 1 | -14.18 | -18.46 | -36.87 | -88.43 | -43 | -56.26 | -79 | -108 |
Operating Margin | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -16.01 | -23.22 | -36.86 | -87.97 | -40.33 | -55.06 | -79 | - |
Net income 1 | -16.01 | -22.81 | -34.51 | -87.97 | -40.33 | -53.83 | -74.65 | -90 |
Net margin | - | - | - | - | - | - | - | - |
EPS 2 | -24.48 | -15.72 | -2.330 | -6.160 | -1.640 | -1.450 | -0.9000 | -0.9300 |
Free Cash Flow 1 | -13.86 | -15.21 | - | - | - | -48 | -67 | -89 |
FCF margin | - | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 3/17/20 | 3/30/21 | 3/24/22 | 3/30/23 | 3/28/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -10.51 | -9.385 | -9.859 | -9.283 | -10.6 | -58.69 | -11.11 | -10.35 | -11.2 | -10.34 | -12.75 | -14.07 | -14.6 | -14.85 |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -10.5 | -9.385 | -9.864 | -9.247 | -10.47 | -58.38 | -10.77 | -9.579 | -10.35 | -9.626 | -12.45 | -13.77 | -14.3 | -14.55 |
Net income 1 | -9.817 | -8.806 | -9.864 | -9.247 | -10.47 | -58.38 | -10.77 | -9.579 | -10.35 | -9.626 | -11.92 | -13.18 | -13.55 | -15.12 |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -0.6600 | -0.6000 | -0.6900 | -0.6500 | -0.7300 | -4.090 | -0.7500 | -0.4000 | -0.3500 | -0.2900 | -0.3900 | -0.3850 | -0.3600 | -0.3500 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/11/21 | 3/24/22 | 5/12/22 | 8/11/22 | 11/14/22 | 3/30/23 | 5/11/23 | 8/10/23 | 11/9/23 | 3/28/24 | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | -13.9 | -15.2 | - | - | - | -48 | -67 | -89 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | 13.10 | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | - | - | - | - | - | 1 | 2 | 2 |
Capex / Sales | - | - | - | - | - | - | - | - |
Announcement Date | 3/17/20 | 3/30/21 | 3/24/22 | 3/30/23 | 3/28/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.44% | 51.12M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.70% | 22.15B | |
-17.37% | 21.02B | |
-8.79% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ELDN Stock
- Financials Eledon Pharmaceuticals, Inc.